Table 1.
Study | miRNAs | Muscle Biopsy | Sample Size | Normalization | Targets | Associated Pathological Signs and Mechanisms | |
---|---|---|---|---|---|---|---|
Gambardella 2010 [48] | miR-206 | ↑ | Vastus lateralis | 7 DM1 4 ctrls |
Hsa-let-7a | ||
Perbellini 2011 [51] | miR-1 * miR-29b/c ** miR-335 miR-33 |
↑ ↓ ↑ ↑ |
Biceps branchi | 15 DM1 14 ctrls |
miR-16 | MEF2a *,1 MET *,1 GATA6 *,1 HAND2 *,1 |
muscle development 1 |
KCNE1 *,2 KCNJ2 *,2 CALM2 *,2 |
Arrhythmia 2 | ||||||
SFRS9 *,3 | Splicing 3 | ||||||
DAG1 **,4 DIABLO **,4 RET **TRIM63 **,4 TGFB3 **,4 |
Atrophy 4 | ||||||
Fernandez-Costa 2012 [52] | miR-1 *** miR-7 **** miR-10 ***** |
↓ ↓ ↓ |
Vastus lateralis Biceps branchi Deltoid |
5 DM1 3 ctrls |
Sno-RNA RNU48 | SOD1 ***,5 SMARCA4 ***,6 NET 1 ***,7 CTSB ****,8 ATG4 ****,9 VCL ****,10 UBE11 *****,11 |
Free radical removal 5 Transcription 6 Apoptosis and signal transduction 7 Proteolysis 8 Autophagy 9 Cytoskeleton 10 Protein localization/activity regulation 11 |
Fritegotto 2017 [53] | miR-1 miR-133a/b miR206 |
↓ ↓ ↑ |
Vastus lateralis | 12 DM1 6 ctrls |
Hsa-let-7a | ||
Ambrose 2017 [52] | miR-1 miR-133a miR-29c |
↓ ↓ ↓ |
Biceps branchi Gastrocnemius Deltoid |
9 DM1 9 ctrls |
Hsa-let-7a |
↑ = upregulation, ↓ = downregulation, DM1 = DM1 patients, ctrls = healthy subjects, colors indicate to which miRNA the targets belong. Normalization stands for the miRNA, either endogenous or spike-in, that has been used to normalize the differentially expressed miRNAs. *, **, ***, ****, *****, indicate to which miRNA the targets belong. 1–11 numbers indicates which Associated Pathological Signs and Mechanisms belong to which target.